Einfluss des Impact-Faktors auf das Berichten einer Fallzahlplanung in Publikationen zu Studien am Beispiel der AMD-Therapie
| Autor: | Stephanie Knippschild, Berit Geis, Sabrina Tulka, Christine Baulig, Frank Krummenauer |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Impact factor
business.industry Significant difference Consolidated Standards of Reporting Trials Guideline Confidence interval law.invention Clinical trial 03 medical and health sciences Ophthalmology 0302 clinical medicine Randomized controlled trial law Sample size determination 030221 ophthalmology & optometry Medicine business 030217 neurology & neurosurgery Demography |
| Zdroj: | Der Ophthalmologe. 117:125-131 |
| ISSN: | 1433-0423 0941-293X |
| Popis: | BACKGROUND For scientific and ethical reasons randomized controlled clinical trials (RCTs) should be based on a sample size calculation. The CONSORT statement, an established publication guideline for transparent study reporting, requires a sample size calculation in every study publication. OBJECTIVE The availability of sample size calculations in RCT publications on treatment of age-related macular degeneration (AMD) was investigated. The primary hypothesis of this investigation compared the prevalence of reported sample size calculations between journals with higher (≥5) versus lower ( |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink